glp-1 allodynia Advances in receptor agonists for pain treatment and their future potential Allodynia and semaglutide: complete guide
Description
Microglial glucagon-like peptide-1 receptor (GLP-1R) activation can alleviate pain
Monthly dosing, oral delivery, and multi-pathway mechanisms are reshaping the patient journey and the strategic playbook
When these drugs activate those receptors, they appear to: Reduce neuroinflammation Improve the brain's ability to clear amyloid and tau Protect connections between neurons Improve brain insulin sensitivity Before you run to your doctor: The nuance matters here
Exaggerated GLP-1 secretion underlies hyperinsulinemic #hypoglycemia in some individuals post #bariatric surgery and contributes to improved beta cell function
Created from PDB ID:1JRJ
